SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation of New Frontier Media, Inc. (NOOF) and Yongye International, Inc. (YONG) and Class Action Against Vertex Pharmaceuticals Inc. (VRTX)
NEW YORK, Oct. 16, 2012 /PRNewswire/ --
New Frontier Media, Inc.
Levi & Korsinsky is investigating the Board of Directors of New Frontier Media, Inc. (NasdaqGS: NOOF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LFP Broadcasting, LLC, an affiliate of L.F.P., Inc., for $2.02 per share plus a contingent cash payment of no more than $0.06 per share if New Frontier Media's available cash balance at the closing of the tender offer—less unpaid transaction expenses—exceeds $11,514,000. At least one analyst set a price target for New Frontier Media stock at $4.00 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/new-frontier-media, or call: 877-363-5972.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
Yongye International, Inc.
Levi & Korsinsky is investigating the Board of Directors of Yongye International, Inc. (NASDAQ: YONG) for possible breaches of fiduciary duty and other violations of state law in connection with the proposed sale of the Company to a consortium led by its Chairman and Chief Executive Officer, Mr. Zishen Wu for $6.60 per share. The company has a reported book value of $7.64 per share for the most recent quarter.
Click here to learn how to join the action: http://zlk.9nl.com/yongye-international-yong, or call: 877-363-5972.
Vertex Pharmaceuticals Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Vertex Pharmaceuticals Inc. (NasdaqGS: VRTX) securities between May 7, 2012 and June 27, 2012.
For more information, click here: http://zlk.9nl.com/vertex-pharmaceuticals-vertex. You have until November 5, 2012 to request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
RELATED LINKS
http://www.zlk.com
More by this Source
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated
May 17, 2013, 12:52 ET
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Star Scientific, Inc. of Class Action Lawsuit and the Deadline of May 24, 2013 to Seek a Lead Plaintiff Position
May 14, 2013, 13:10 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Market Leader, Inc. in Connection with the Sale of the Company to Trulia, Inc.
May 10, 2013, 12:54 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.






